Setting your location helps us to show you nearby providers and locations based on your healthcare needs.
Your Location is set to Change My Location
Cone Health wants to help you get well and stay well. This section provides tools and information to achieve good health and maintain your well-being.
Learn what community resources are available to help you get well and stay well.
View health and wellness news you can use from Cone Health providers on
View Advanced Search OptionsView All Doctors
View All Locations
Home > Patient & Family Resources > Health Library > Hemolytic disease of the newborn
NOTICE: For the safety of our patients and employees, masks are still required at all Cone Health facilities.COVID-19 Info: Current Trends | Vaccine Scheduling | Visitor Guidelines | COVID-19 Testing | More
Hemolytic disease of the newborn (also called erythroblastosis fetalis) is a serious condition that may occur when the blood types of a mother and her baby do not match. Substances (antibodies) in the mother's blood cross the placenta and may destroy the red blood cells of the fetus.
After birth, a baby with hemolytic disease may be treated with a blood transfusion.
Current as of: February 10, 2021
Author: Healthwise Staff
Medical Review:Adam Husney MD - Family Medicine & Sarah Marshall MD - Family Medicine & Kathleen Romito MD - Family Medicine & John Pope MD - Pediatrics
To learn more about Healthwise, visit Healthwise.org.
© 1995-2021 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Subscribe to our Wellness Matters e-newsletter, a monthly snapshot of the some of great wellness content from Cone Health providers.